Immunoradiometric Assays for Human Coagulation Factor VII Using Polyclonal Antibodies Against the Ca(II)-Dependent and Ca(II)-Independent Conformation

Summary

Human coagulation factor VII is a trace plasma protein belonging to the vitamin K-dependent factors. Two specific and sensitive immunoradiometric assays for factor VII were developed using immunopurified rabbit antibodies against the Ca(II)-independent and Ca(II)-dependent conformation of factor VII. Both assays were insensitive to the activation state of factor VII. The distribution of factor VII antigen was studied in 40 healthy individuals and the antigen level in normal plasma was calculated to be 0.52-0.62 μg/ml. The two assays were used in a comparative study of factor VII procoagulant activity and factor VII antigen in patients treated with oral anticoagulants.

Key words

Factor VII - Immunoradiometric assay - Calcium - Oral anticoagulation - Factor VII deficiency

• References

• 1 Østerud B. Activation pathways of the coagulation system in normal haemostasis. Scand J Haematol 1984; 32: 337-345
• 2 Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264
• 3 Morrison SA, Jesty J. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma. Blood 1984; 63: 1338-1347
• 4 Broze Jr GJ, Majerus PW. Purification and properties of human coagulation factor VII. J Biol Chem 1980; 255: 1242-1247
• 5 Bajaj SP, Rapaport SI, Brown SF. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 1981; 256: 253-259
• 6 Masys DR, Bajaj SP, Rapaport SI. Activation of human factor VII by activated factors IX and X. Blood 1982; 60: 1143-1150
• 7 Seligsohn U, Østerud B, Brown SF, Griffin JH. Activation of human factor VII in plasma and in purified systems. Roles of activated factor IX, kallikrein and activated factor XII. J Clin Invest 1979; 64: 1056-1065
• 8 Laake K, Østerud B. Activation of purified plasma factor VII by human plasmin, plasma kallikrein and activated components of the human intrinsic blood coagulation system. Thromb Res 1974; 5: 759-772
• 9 Broze Jr GJ, Majerus PW. Isolation and properties of human factor VII. Clin Res 1979; 27: 459A
• 10 Dam-Mieras MCE van, Hemker HC. Half-life time and control frequency of vitamin K-dependent coagulation factors. Theoretical considerations on the place of factor VII in the control of oral anticoagulant therapy. Haemostasis 1983; 13: 201-208
• 11 Mariani G, Mazzucconi MG, Solinas S, Avvisati G, Chistolini A, Morretti T. Studies on PIVKA VII. Haemostasis 1984; 14: 238-243
• 12 Kisiel W, McMullen BA. Isolation and characterization of human factor Vila. Thromb Res 1981; 22: 375-380
• 13 Deijk WA van, Dam-Mieras MCE van, Muller AD, Hemker HC. Evaluation of a coagulation assay determining the activity state of factor VII in plasma. Haemostasis 1983; 13: 192-197
• 14 Seligsohn U, Østerud B, Rapaport SI. Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII. Blood 1978; 52: 978-988
• 15 Goodnight Jr SH, Feinstein DI, Østerud B, Rapaport SI. Factor VII antibody neutralizing material in hereditary and acquired factor VII deficiency. Blood 1971; 38: 1-8
• 16 Denson K WE. The levels of factors II, VII, IX and X by antibody neutralisation techniques in the plasma of patients receiving phenan-dione therapy. Br J Haematol 1971; 20: 643-648
• 17 Briët E, Loeliger EA, Tilburg NH van, Veltkamp JJ. Molecular variant of factor VII. Thromb Haemostas 1976; 35: 289-294
• 18 Fair DS. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
• 19 Mikami S, Tuddenham E GD. Studies on immunological assay of vitamin K-dependent factors. I. Measurement of factor VII antigen by radioimmunoassay. Br J Haematol 1986; 62: 171-181
• 20 Broze Jr GJ, Hickman S, Miletich JP. Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. J Clin Invest 1985; 76: 937-946
• 21 Loeliger EA, Lewis SM. Progress in laboratory control of oral anticoagulants. Lancet 1982; 2: 318-320
• 22 Bertina RM, Orlando M, Tiedemann-Alderkamp G HJ. Preparation of a human factor VII deficient plasma. Thromb Res 1978; 13: 537-541
• 23 Bom V JJ, Ram IE, Alderkamp G HJ, Reinalda-Poot JH, Bertina RM. Application of factor VH-Sepharose affinity chromatography in the purification of human tissue factor apoprotein. Thromb Res 1986; 42: 635-643
• 24 Broze Jr GJ, Majerus PW. Human factor VII. Meth Enzymol 1980; 80: 228-237
• 25 Tankersley DL, Alving BM, Finlayson JS. Preparation of β-XIIa (Hageman factor fragment) from human plasma. Thromb Res 1982; 25: 307-317
• 26 Fraker PJ, Speck Jr JC. Protein and cell membrane iodonations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenyl-glycoluril. Biochem Biophys Res Commun 1978; 80: 849-857
• 27 Bertina RM, Wijngaarden A van, Reinalda-Poot JH, Poort SR, Bom V JJ. Determination of plasma protein S - the protein cofactor of activated protein C. Thromb Haemostas 1985; 53: 268-272
• 28 Bertina RM, Broekmans AW, Linden IK van der, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
• 29 Bertina RM, Linden I K van der. Inhibitor neutralisation assay and electroimmunoassay of human factor IX (Christmas factor). Clin Chim Acta 1977; 77: 275-286
• 30 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantitaties of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 31 Gjønnoes H. Cold promoted activation of factor VII. I. Evidence for the existence of an activator. Thrombos Diathes Haemorrh 1972; 28: 155-168
• 32 Rao L VM, Bajaj SP, Rapaport SI. Activation of human factor VII during clotting in vitro. Blood 1985; 65: 218-226
• 33 Mariani G, Mazzucconi MG. Factor VII congenital deficiency. Clinical picture and classification of the variants. Haemostasis 1983; 13: 169-177
• 34 Meade TW, North W RS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-1054
• 35 Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to a VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249-258
• 36 Van der Meer J, Hemker HC, Loeliger EA. Pharmacological aspects of vitamin K₁ A clinical and experimental study in man. Thrombos Diathes Haemorrh 1968 29
• 37 Poort SR, Linden IK van der, Krommenhoek-van Es C, Briët E, Bertina RM. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays. Thromb Haemostas 1986; 55: 122-128